Last quarter (Q3 2022), Biosergen AB's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Biosergen AB's net income was $-14.50M. See Biosergen AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20
Total Revenue	$ 2.71M	$ 0.00	$ 0.00
Cost of Revenue	$ 300.00K	$ 178.00K	$ 0.00
Gross Profit	$ 2.41M	$ -178.00K	$ 0.00
Operating Expense	$ 36.49M	$ 33.90M	$ 6.23M
Operating Income	$ -34.08M	$ -34.08M	$ -6.23M
Net Non Operating Interest Income Expense	$ -124.00K	$ ―	$ ―
Other Income Expense	$ ―	$ ―	$ ―
Pretax Income	$ -34.20M	$ -34.32M	$ -6.72M
Tax Provision	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -34.20M	$ -34.32M	$ -6.72M
Basic EPS	$ -0.67	$ -1.08	$ -0.29
Diluted EPS	$ -0.67	$ -1.08	$ -0.29
Basic Average Shares	$ 87.83M	$ 31.66M	$ 23.10M
Diluted Average Shares	$ 87.83M	$ 31.66M	$ 23.10M
Dividend Per Share	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―
Total Expenses	$ 36.79M	$ 34.08M	$ 6.23M
Net Income From Continuing And Discontinued Operation	$ -34.20M	$ -34.32M	$ -6.72M
Normalized Income	$ -34.20M	$ -34.32M	$ -6.72M
Interest Expense	$ 146.00K	$ ―	$ ―
EBIT	$ -34.08M	$ -34.08M	$ -6.23M
EBITDA	$ -34.08M	$ -34.08M	$ -6.23M

Currency in USD

Biosergen AB Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing